Skip to main navigation Skip to search Skip to main content

Quality of life in metastatic pancreatic cancer patients receiving liposomal irinotecan plus 5-fluorouracil and leucovorin

  • Richard A. Hubner
  • , Antonio Cubillo
  • , Jean Frédéric Blanc
  • , Davide Melisi
  • , Daniel D. Von Hoff
  • , Andrea Wang-Gillam
  • , Li Tzong Chen
  • , Claus Becker
  • , Khalid Mamlouk
  • , Bruce Belanger
  • , Yoojung Yang
  • , Floris A. de Jong
  • , Jens T. Siveke
  • The Christie NHS Foundation Trust
  • HM Universitario Madrid Sanchinarro
  • Universidad CEU San Pablo
  • Hôpital Haut-leveque
  • University of Verona
  • Translational Genomics Research Institute
  • Washington University in St. Louis
  • National Institute of Cancer Research
  • Merrimack Pharmaceuticals, Inc
  • Oncology R&D
  • Shire
  • University Hospital of Essen
  • German Cancer Research Center

Research output: Contribution to journalArticlepeer-review

44 Scopus citations

Fingerprint

Dive into the research topics of 'Quality of life in metastatic pancreatic cancer patients receiving liposomal irinotecan plus 5-fluorouracil and leucovorin'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science